Hoffman Michael B
SEC CIK 1290208 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANVS | Annovis Bio, Inc. | Dir, 10% | 3.36M | $4.26M | — | 17 | 2022-01-04 | 2026-05-20 |
Most active insiders at ANVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoffman Michael B | Dir | $4.26M | — |
| 2 | Maccecchini Maria-Luisa | Pres, CEO, Dir | $200.0K | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-21 20:11 | 2026-05-20 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $1.87 | +76.3K | 3.36M | +2% | +$142.8K |
| 2026-04-03 17:06 | 2026-04-02 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $2.10 | +713.8K | 3.29M | +28% | +$1.50M | |
| M | 2025-12-08 | 2025-12-08 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $4.31 | +45.0K | 2.56M | +2% | +$193.8K |
| M | 2025-11-25 | 2025-11-24 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $4.08 | +39.2K | 2.48M | +2% | +$159.9K |
| MA | 2025-11-25 | 2025-11-24 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $4.08 | +39.2K | 2.50M | +2% | +$159.9K |
| M | 2025-11-21 | 2025-11-21 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $3.50 | +20.0K | 2.49M | +0.8% | +$69.9K |
| 2025-11-18 | 2025-11-14 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $2.11 | +15.0K | 2.47M | +0.6% | +$31.6K | |
| 2025-11-12 | 2025-10-28 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | P - Purchase | $2.05 | +975.6K | 2.46M | +66% | +$2.00M | |
| M | 2025-09-03 | 2025-08-29 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | A - Grant | $2.29 | +15.0K | 1.47M | +1% | +$34.4K |
| M | 2025-08-20 | 2025-08-19 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | A - Grant | $2.59 | +18.6K | 1.46M | +1% | +$48.3K |
| M | 2025-06-16 | 2025-06-13 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | A - Grant | $2.80 | +25.0K | 1.45M | +2% | +$70.0K |
| 2025-06-02 | 2025-05-29 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir | A - Grant | $2.43 | +5,000 | 1.42M | +0.4% | +$12.2K | |
| AI | 2023-11-22 | 2023-11-20 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir, 10% | A - Grant | $6.10 | +163.9K | 223.4K | +276% | +$999.7K |
| I | 2023-11-21 | 2023-11-20 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir, 10% | A - Grant | $6.07 | +164.7K | 224.2K | +277% | +$1.00M |
| I | 2023-04-11 | 2023-04-07 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir, 10% | A - Grant | $12.61 | +59.5K | 59.5K | New | +$750.0K |
| DM | 2022-01-05 | 2022-01-04 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir, 10% | F - Tax | $19.78 | -6,748 | 1.41M | -0.5% | -$133.5K |
| DM | 2022-01-05 | 2022-01-04 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Dir, 10% | M - OptEx | $3.59 | +37.1K | 1.42M | +3% | +$133.5K |
Purchase Sale Sale after option exercise All abbreviations